Metabolic Syndrome in Heart Failure: Friend or Foe?

Michele Arcopinto; Alessandra Schiavo; Andrea Salzano; Eduardo Bossone; Roberta D'Assante; Fabio Marsico; Pablo Demelo-Rodriguez; Ragavendra R. Baliga; Antonio Cittadini; Alberto M. Marra

doi:10.1016/j.hfc.2019.02.004

Metabolic Syndrome in Heart Failure: Friend or Foe?

Michele Arcopinto, Alessandra Schiavo, Andrea Salzano, Eduardo Bossone, Roberta D'Assante, Fabio Marsico, Pablo Demelo-Rodriguez, Ragavendra R. Baliga, Antonio Cittadini, Alberto M. Marra

Research output: Contribution to journal › Review article › peer-review

Abstract

The interplay between metabolic syndrome (MetS)and heart failure (HF)is intricate. Population studies show that MetS confers an increased risk to develop HF and this effect is mediated by insulin resistance (IR). However, obesity, a key component in MetS and common partner of IR, is protective in patients with established HF, although IR confers an increased risk of dying by HF. Such phenomenon, known as “obesity paradox,” accounts for the complexity of the HF-MetS relationship. Because IR impacts more on outcomes than MetS itself, the former may be considered the actual target for MetS in HF patients.

Original language	English
Pages (from-to)	349-358
Number of pages	10
Journal	Heart Failure Clinics
Volume	15
Issue number	3
DOIs	https://doi.org/10.1016/j.hfc.2019.02.004
Publication status	Published - Jul 2019

Keywords

Heart failure
Insulin resistance
Metabolic syndrome
Prognosis
Risk stratification

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.hfc.2019.02.004

Cite this

Metabolic Syndrome in Heart Failure : Friend or Foe? / Arcopinto, Michele; Schiavo, Alessandra; Salzano, Andrea; Bossone, Eduardo; D'Assante, Roberta; Marsico, Fabio; Demelo-Rodriguez, Pablo; Baliga, Ragavendra R.; Cittadini, Antonio; Marra, Alberto M.

In: Heart Failure Clinics, Vol. 15, No. 3, 07.2019, p. 349-358.

Research output: Contribution to journal › Review article › peer-review

@article{66a650d02a9446f292b308d7a0473676,

title = "Metabolic Syndrome in Heart Failure: Friend or Foe?",

abstract = "The interplay between metabolic syndrome (MetS)and heart failure (HF)is intricate. Population studies show that MetS confers an increased risk to develop HF and this effect is mediated by insulin resistance (IR). However, obesity, a key component in MetS and common partner of IR, is protective in patients with established HF, although IR confers an increased risk of dying by HF. Such phenomenon, known as “obesity paradox,” accounts for the complexity of the HF-MetS relationship. Because IR impacts more on outcomes than MetS itself, the former may be considered the actual target for MetS in HF patients.",

keywords = "Heart failure, Insulin resistance, Metabolic syndrome, Prognosis, Risk stratification",

author = "Michele Arcopinto and Alessandra Schiavo and Andrea Salzano and Eduardo Bossone and Roberta D'Assante and Fabio Marsico and Pablo Demelo-Rodriguez and Baliga, {Ragavendra R.} and Antonio Cittadini and Marra, {Alberto M.}",

year = "2019",

month = jul,

doi = "10.1016/j.hfc.2019.02.004",

language = "English",

volume = "15",

pages = "349--358",

journal = "Heart Failure Clinics",

issn = "1551-7136",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Metabolic Syndrome in Heart Failure

T2 - Friend or Foe?

AU - Arcopinto, Michele

AU - Schiavo, Alessandra

AU - Salzano, Andrea

AU - Bossone, Eduardo

AU - D'Assante, Roberta

AU - Marsico, Fabio

AU - Demelo-Rodriguez, Pablo

AU - Baliga, Ragavendra R.

AU - Cittadini, Antonio

AU - Marra, Alberto M.

PY - 2019/7

Y1 - 2019/7

N2 - The interplay between metabolic syndrome (MetS)and heart failure (HF)is intricate. Population studies show that MetS confers an increased risk to develop HF and this effect is mediated by insulin resistance (IR). However, obesity, a key component in MetS and common partner of IR, is protective in patients with established HF, although IR confers an increased risk of dying by HF. Such phenomenon, known as “obesity paradox,” accounts for the complexity of the HF-MetS relationship. Because IR impacts more on outcomes than MetS itself, the former may be considered the actual target for MetS in HF patients.

AB - The interplay between metabolic syndrome (MetS)and heart failure (HF)is intricate. Population studies show that MetS confers an increased risk to develop HF and this effect is mediated by insulin resistance (IR). However, obesity, a key component in MetS and common partner of IR, is protective in patients with established HF, although IR confers an increased risk of dying by HF. Such phenomenon, known as “obesity paradox,” accounts for the complexity of the HF-MetS relationship. Because IR impacts more on outcomes than MetS itself, the former may be considered the actual target for MetS in HF patients.

KW - Heart failure

KW - Insulin resistance

KW - Metabolic syndrome

KW - Prognosis

KW - Risk stratification

UR - http://www.scopus.com/inward/record.url?scp=85063894992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063894992&partnerID=8YFLogxK

U2 - 10.1016/j.hfc.2019.02.004

DO - 10.1016/j.hfc.2019.02.004

M3 - Review article

C2 - 31079693

AN - SCOPUS:85063894992

VL - 15

SP - 349

EP - 358

JO - Heart Failure Clinics

JF - Heart Failure Clinics

SN - 1551-7136

IS - 3

ER -

Metabolic Syndrome in Heart Failure: Friend or Foe?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this